Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China

CompletedOBSERVATIONAL
Enrollment

1,537

Participants

Timeline

Start Date

March 9, 2017

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

No Treatment

No treatment

Trial Locations (18)

100043

Peking University Shougang Hospital, Beijing

110072

Shengjing Hospital of China Medical University, Shenyang

116011

First Affiliated Hospital of Dalian Medical University, Dalian

210006

Nanjing First Hospital, Nanjing

210029

Integrated Chinese and Western Medicine Hospital, Nanjing

215006

The First Affiliated Hospital of Soochow University, Suzhou

230022

The First Affiliated Hospital of Anhui Medical University, Hefei

266005

The affiliated hospital of medicalcollege qingdao university, Qingdao

518020

Shenzhen People's Hospital, Shenzhen

610000

Chinese Traditional Medicine Hospital of Sichuna Provinc, Chengdu

610041

West China Hospital, Chengdu

Unknown

Beijing Hospital, Beijing

Beijing Pinggu Hospital, Beijing

China Meitan General Hospital, Beijing

First Hospital of Jilin University, Changchun

Forth Clinical Hospital of Harbin Medical University, Harbin

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

Affiliated Hospital of Nantong University, Nantong

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY